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Abstract
Background: Poor rates of linkage from HIV diagnosis to ART initiation are a major barrier to universal coverage of ART in
sub-Saharan Africa, with reasons for failure poorly understood. In the first study of this kind at primary care level, we
investigated the pathway to care in the Malawian National Programme, one of the strongest in Africa.
Methods and Findings: A prospective cohort study was undertaken at two primary care clinics in Blantyre, Malawi. Newly
diagnosed HIV-positive adults (.15 years) were followed for 6-months to assess completion of eligibility assessments,
initiation of ART and death. Two hundred and eighty participants were followed for 82.6 patient-years. ART eligibility
assessments were problematic: only 134 (47.9%) received same day WHO staging and 121 (53.2%) completed assessments
by 6-months. Completion of CD4 measurement (stage 1/2 only) was 81/153 (52.9%). By 6-months, 87/280 (31.1%) had
initiated ART with higher uptake in participants who were ART eligible (68/91, 74.7%), and among participants who received
same-day staging (52/134 [38.8%] vs. 35/146 [24.0%] p = 0.007). Non-completion of ART eligibility assessments (adjusted
hazard ratio: 0.11, 95% CI: 0.06–0.21) was associated with failure to initiate ART. Retention in pre-ART care for non-ART
initiators was low (55/193 [28.5%]). Of the 15 (5.4%) deaths, 11 (73.3%) occurred after ART initiation.
Conclusions: Although uptake of ART was high and prompt for patients with known eligibility, there was frequent failure to
complete eligibility assessment and poor retention in pre-ART care. HIV care programmes should urgently evaluate the way
patients are linked to ART. In particular, there is a critical need for simplified, same-day ART eligibility assessments, reduced
requirements for hospital visits, and active defaulter follow-up.
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Introduction
Malawi, with a population of nearly 14 million people is the 10th
poorest country in the world and is among the countries hardest
hit by the HIV pandemic [1]. The most recent estimates show that
12% of adults are infected with HIV [2]. Despite this bleak
picture, Malawi has had tremendous success in scaling-up
antiretroviral therapy (ART) delivery using a public health
approach that has incorporated decentralisation of treatment
delivery to primary health care level, task-shifting from clinicians
to nurses, and a nationwide quarterly reporting system [3,4].
Nevertheless, potential limitations remain. Linkage into HIV
care following a positive test is known to be problematic in many
African countries [5], and is not tracked in the Malawian
programme. Between January 2008 and March 2011, 5,663,852
Malawians received HIV testing and counselling (HTC), with
653,004 (12%) testing HIV-positive [6] and 218,335 (33% of all
tested positive) initiated ART [6]. However, the number of those
testing positive who were eligible for ART initiation is not
captured by the programme, and nor are any data collected on the
interval between testing positive and ART initiation, if eligible.
Therefore, these very encouraging figures may nonetheless include
a substantial proportion of HIV-positive Malawians with failed or
unduly delayed ART initiation [7].
Recent studies from Southern Africa have highlighted large
gaps in understanding of patient flow in the pre-ART period
(between HIV diagnosis and initiation of ART). A systematic
review highlighted high rates of attrition before ART initiation [5]
which contribute to the high pre- and early-ART mortality rates
observed in many sub-Saharan African programmes [8,9]. Only
two prospective cohort studies have examined linkage to ART in
sub-Saharan Africa [10,11], both based in South Africa. No
studies to date have described outcomes for individuals tested in
primary care, where HIV services are increasingly delivered.
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This prospective cohort study was undertaken in primary health
care clinics in Blantyre Malawi. The objectives were to describe
progression throughout the HIV care pathway under program-
matic conditions, to estimate the proportion of patients diagnosed
HIV-positive who completed ART assessments and started ART.
We also aimed to identify key points of attrition from the HIV care
pathway and to investigate individual risk factors for failure.
Methods
Ethics Statement
Ethical approval for the study was obtained from the Research
Ethics Committees of the College of Medicine of Malawi and
Liverpool School of Tropical Medicine. All participants provided
written informed consent (or independently-witnessed thumbprint
for illiterate participants). Both Research Ethics Committees
approved witnessed thumbprint consent for illiterate participants.
We did not require written (or witnessed thumbprint) informed
consent from the guardian of participants aged between 16 and 18
years old. In the Malawian national HIV care guidelines, guardian
consent is not required for HIV testing for individuals aged 15
years and over. Both Research Ethics Committees approved this
consent procedure for participants between 16 and 18 years old.
Study Design, Population and Procedures
A prospective cohort study was carried out between January
and September 2011. Two primary health care clinics (Ndirande
Health Centre and Chilomoni Health Centre) located in the
northwest of Blantyre were selected as study sites as they were the
largest primary clinic providers of ART, having initiated
a cumulative total of 5720 people onto ART [6].
During the 3-month recruitment period, study research
assistants undertook exit interviews with clinic attendees immedi-
ately after HTC. Interviews were held in a private room.
Individuals who met study eligibility criteria (.15 years old with
confirmed HIV infection) were invited to participate. Due to clinic
workload and limited availability of private space for interview,
a maximum of 6 participants were recruited from each clinic per
day.
Trained research assistants administered a baseline question-
naire, extracted clinical data from patient-carried records and
clinic HTC registers and carried out WHO clinical staging.
Participants were then advised to follow instructions for further
HIV care given to them by routine clinic staff. To obtain an
estimate of total clinic attendances during the study period,
records of all adult (.15 years) clinic attendances were extracted
from clinic registers.
In order to minimise risk of inadvertent disclosure of HIV status
during follow-up, participants were asked to consent to follow-up
by home-based tracing in the event of non-return by the end of the
follow-up period. All participants consented to home-based
tracing.
Ascertaining Outcomes on the HIV Care Pathway
At the time of the study, Malawian ART eligibility criteria were
based on WHO clinical staging (eligible if stage 3 or 4), with CD4
criteria of ,250 cells/ul if in WHO stage 1 or 2 [12]. Guidelines
were the same for pregnant women, except that single dose
nevirapine and one week of zidovudine were given if not started on
triple therapy. In the clinics, HTC is performed by counsellors
and, following HIV diagnosis, patients are referred to clinicians
(clinical officers, nurses and midwifes) for WHO staging. Patients
in WHO stage 1/2 were referred for CD4 count measurement by
the assessing clinician. At the time of the study, completion of CD4
count measurement required at least two attendances at the city’s
central hospital: one to have blood drawn and one to collect the
result. The patient then brought the CD4 count result back to the
primary health care centre for clinician review. Following ART
initiation, patients attended routine follow-up on a monthly basis
at the clinics.
Guidelines for pre-ART care recommended life-long follow-up
through general medical outpatient clinics with daily co-trimox-
azole prophylaxis and 6-monthly reassessment for ART eligibility.
In this study, ‘‘retained in pre-ART care’’ was defined as: currently
taking co-trimoxazole or having collected co-trimoxazole in the
last 3-months; or having attended an ART support group meeting
or pre-ART education classes in past 3-months; and not having
died or been lost to follow-up. Participants who ‘‘transferred’’ to
another clinic, but who were traced to home were defined as
retained in care. Participants who did not attend either study clinic
for 3- and 6-month appointments, and who could not be traced
after three home visits at both 3 and 6 months, were defined as lost
to follow-up.
Participants were followed-up at 3-months and 6-months after
their HIV diagnosis with questionnaires and inspection of clinic
registers and patient carried records. For participants who had not
returned to the clinic by the end of each follow-up period, research
assistants commenced telephone and home tracing. At home visits,
questionnaires and review of patient carried records were carried
out. Where the participant had died, household members were
asked to provide the date of death and the participant’s patient-
carried record.
Statistical Methods
Self-rated general health was assessed on a 4-point Likert-type
scale [13]. A household wealth scale was constructed using the
proxy means test method [14], based on the 1998 Malawi
Integrated Household Survey [15]. The proxy means test
approach uses eight household variables that have been shown
to be correlated with the consumption level of the household, thus
allowing participants to be wealth-ranked on their ability to meet
household consumption needs [16].
Participant characteristics were stratified into two groups
(pregnant women vs. men and non-pregnant women) as the clinic
pathway for these groups were different (pregnant women received
provider-initiated HTC in the antenatal clinic whereas men and
non-pregnant women were tested in the outpatient clinics) and
baseline characteristics of men and non-pregnant women were
found to be similar.
Time-at-risk in the study was estimated as the period between
date of HIV diagnosis and date of ART initiation, or completion
of 6-months follow-up or death in the event of non-initiation of
ART. Data on participants who were lost-to-follow-up were right-
censored at the midpoint between their last follow-up assessment
and the date of their next expected follow-up visit. Cox regression
analysis was used to examine associations with initiation of ART.
In constructing the multivariate regression model, variables
significant at the p,0.10 level were included using a forward
step-wise procedure.
Results
Clinic Attendances, HTC Episodes and Cohort
Characteristics
During the three months recruitment period (January to April
2011), there were 18,021 adult (.15 years old) attendances at the
two study primary care clinics Baseline characteristics have been
previously reported [17]. In brief, there were 2,398 HTC episodes
Linkage to ART at Primary Care Level
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during the 18,021 clinic attendances (13.3%) and 444 confirmed
HIV infections, giving a positivity rate of 18.5% (Figure 1).
Following completion of HTC procedures, 280 newly diagnosed
HIV-positive adults were recruited in to the cohort, with 84
declining to participate and 80 not recruited because of exceeding
the study recruitment limit of six participants per day (Figure 1).
Seventy-five per cent of participants were women (211/280), of
whom 57.3% (121/211) were pregnant (Table 1). Pregnant
women were more likely to be younger (median 25 years [IQR:
21–30] vs. 31years [interquartile range [IQR]: 27–37]) un-
employed (71.1% vs. 44.7%), to have previously tested for HIV
(57.9% vs. 37.1%), to be married (90.9% vs. 66.7%) and to be
from a relatively wealthier household (27.7% vs. 23.7% in
wealthiest quartile) than men and non-pregnant women. On
self-rated general health (18.9% vs. 1.7% self-rated poor), study
assessed WHO clinical stage (81.1% vs. 37.2% in WHO stage 3 or
4) and CD4 count (median 240 cells/ul [IQR: 143–376] vs. 373
cells/ul [236–527]), men and non-pregnant women received HTC
at a more advanced stage of illness than pregnant women (Table 1).
Primary Cohort Outcome: ART Initiation at 6-Months
The 280 cohort participants were followed-up for 82.6 patient-
years. By 6-months, 87/280 (31.1%) had initiated ART, with 32
(11.4%) lost to follow-up (Figure 1). There were 25/89 (28.1%)
initiations from participants who were assessed as WHO stage 1 or
2 by same-day WHO staging, and 27/45 (60.0%) of those who
were WHO stage 3 or 4. Overall participants who did not receive
same-day WHO staging assessment were substantially less likely to
initiate ART (35/146 [24.0%] vs. 52/134 [38.8%], p = 0.007–
Figure 2). Twenty five per cent (6/24) participants who were
assessed by clinicians as not ART eligible initiated ART.
Of the 91 participants who had met national ART eligibility
criteria through routine clinic assessments over 6-months, 68
(74.7%) initiated ART. The median number of days to ART
initiation was 47 (interquartile range [IQR]: 21–74). Men (34
days, IQR: 19–57) had a shorter time to ART initiation than
pregnant (median 56 days, IQR: 47–87), and non-pregnant
women (median 49 days, IQR: 21–85). This may have been
because pregnant women were more likely to be assessed in WHO
stage 1 or 2 and to have a higher median CD4 count (Table 1).
Kaplan-Meier plots (Figure 3) showed that ART initiation was
higher in men (210 per 100 person-years, 95% CI: 122–226) and
non-pregnant women (166 per 100 person-years, 95% CI: 150–
294) compared to pregnant women (31 per 100 person-years, 95%
CI: 18–53; logrank test: p,0.001). Participants who had poor
(350 per 100 person-years, 95% CI: 223–548) or fair (212 per 100
person-years, 95% CI: 159–283) self-rated general health had
uptake of ART compared to participants who had self-rated good
(53 per 100 person-years, 95% CI: 32–87) or excellent (24 per 100
person-years, 95% CI: 11–53) general health (logrank test:
p,0.001).
Factors Associated with ART Initiation
On univariate analysis (Table 2), men (hazard ratio [HR]: 1.29,
95% CI: 0.81–2.04), older participants (HR: 1.05, 95% CI: 1.04–
1.07), participants who had fair (HR: 8.48, 95% CI: 3.62–19.88)
or poor (HR: 13.70, 95% CI: 5.44–34.51) self-rated general
health, participants in WHO stage 3 or 4 (HR: 3.25, 95% CI:
1.89–5.60) and participants who received same-day WHO staging
Figure 1. Flow diagram of cohort outcomes. ART: antiretroviral therapy.
doi:10.1371/journal.pone.0044794.g001
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(HR: 1.66, 95% CI: 1.08–2.55) were more likely to initiate ART.
Pregnant women (HR: 0.20, 95% CI: 0.11–0.40), participants who
were assessed as not ART eligible (HR: 0.16, 95% CI: 0.07–0.36)
and who didn’t complete ART eligibility assessments (HR: 0.07,
95% CI: 0.04–0.12) were less likely to initiate ART.
Table 1. Baseline characteristics of cohort members.
Characteristic
Men and non-pregnant
women % Pregnant women %
Total 159 100 121 100
Age (years) – median (IQR) 31 27–37 25 21–30
Marital status
Married 106 66.7 110 90.9
Divorced 24 15.1 2 1.7
Never married 18 11.3 8 6.6
Widowed 11 6.9 1 0.8
BMI (kg/m2) – median (IQR) 21 19–23 24 22–26
Employment status
Not in formal employment 71 44.7 86 71.1
In formal employment 88 55.3 35 28.9
Literacy
Able to read a newspaper 129 81.1 98 81.0
Illiterate 30 18.9 23 19.0
Wealth quartile6
Poorest quartile 42 31.1 14 14.9
Next poorest quartile 35 25.9 23 24.5
Next wealthiest quartile 26 19.3 31 33
Wealthiest quartile 32 23.7 26 27.7
Previously tested for HIV
Yes 59 37.1 70 57.9
No 100 62.9 51 42.1
Tuberculosis history
Current 6 3.8 0 0
Previous 9 5.7 6 5.0
Never 144 90.6 115 95.0
Self-rated general health
Excellent 21 13.2 48 39.7
Good 38 23.9 51 42.1
Fair 70 44 20 16.5
Poor 30 18.9 2 1.7
WHO clinical stage*
Stage 1 or 2 30 18.9 76 62.8
Stage 3 or 4 129 81.1 45 37.2
Received same day WHO staging 89 56.0 45 37.2
ART eligibility at 6-months¡
ART eligible 136 85.5 47 38.8
Not ART eligible 7 4.4 12 9.9
Not fully assessed 16 10.1 62 51.2
CD4 count (median, IQR) cells/ul1 240 143–376 373 236–527
6Proxy means test for household wealth is a continuous variable constructed from: asset ownership (fridge, car or motorbike, bed); mean household size; squared mean
household size; mean age of household head; education level of household head; mean number of salaried household members; household lighting source in
electricity or gas. Categorised into quartiles to describe differences in wealth between groups.
*Study assessed WHO stage: participants were independently staged by research assistants.
¡ART eligibility defined as meeting national ART criteria (CD4,250 cells/ul or WHO stage 3 or 4) on routine clinic assessments.
1Where blood taken and results available at primary clinic (men and non-pregnant women [n = 51], pregnant women [n = 30]).
doi:10.1371/journal.pone.0044794.t001
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On multivariate adjusted analysis failure to complete ART
eligibility assessments (adjusted HR: 0.11, 95% CI: 0.06–0.21) or
assessment as not ART eligible (adjusted HR: 0.16, 95% CI: 0.07–
0.36) were significantly associated with non-initiation of ART. Fair
(adjusted HR: 2.87, 95% CI:1.11–7.40) or poor self-rated general
health (adjusted HR: 3.16, 95% CI: 1.11–8.93) were associated
with ART initiation. However, male sex (adjusted HR: 1.29, 95%
0.78–2.14), pregnancy in women (adjusted HR: 0.58, 95% CI:
0.28–1.21), and age (adjusted HR: 1.01, 95% CI: 0.99–1.04) were
no longer associated with ART initiation.
Evaluation of Patient Flow Towards ART Initiation and
Retention in Pre-ART Care for Non-ART Eligible
Participants
Following HIV diagnosis, routine clinic WHO clinical staging
was completed on the same day for 134 (47.9%) participants with
the remainder asked to return to the clinic on an alternative day
when a clinician was available, or reporting no clear instructions.
By 6-months, a further 45 (16.1%) had completed routine clinic
WHO staging. Overall, 61/179 (34.1%) were in WHO stage 3 or
4.
In total, 153/280 (54.6%) participants were referred by health
workers for CD4 counts measurement, of whom 99 (64.7%) had
blood taken and 81 (52.9%) had received results by 6-months. The
median CD4 count was 294 cells/ul (interquartile range: 173–473
cells/ul) and 40/57 (70.2%) had a CD4 count of ,250 cells/ul.
Median CD4 count was lower in men and non-pregnant women
(240 cells/ul, IQR: 143–376) than in pregnant women (373 cells/
ul, IQR: 236–527, p = 0.039). The median delay from HIV
diagnosis to ART initiation for participants with CD4 count ,250
cells/ul was 63 days (IQR: 47–81 days).
Overall, 91 (32.5%) participants had met National ART criteria
by 6-months, with 30 (10.7%) not ART eligible and 159 (56.8%)
not fully assessed. Failure to complete assessments was higher in
pregnant women (95/121, 78.5%) compared to men (27/69,
39.1%) and non-pregnant women (37/90, 41.1%, p,0.001).
Participants who were not WHO staged on the same day as
HIV diagnosis were significantly less likely to complete ART
eligibility assessments than participants who had same-day WHO
staging (74/134 [55.2%] vs. 32/146 [21.9%]; p,0.001– Figure 3).
By 6-months, participants who received same-day WHO staging
were more likely (although not statistically significant) to be
retained in any HIV care (either initiated ART or retained in pre-
ART) than participants who did not receive day WHO staging
(71/134 [54.5%] vs. 69/146 [47.3%]; p= 0.288).
Retention in pre-HIV care was poor for the 193 participants
who had not initiated ART by 6-months: 138 (72%) had dropped
out, with 4 (2.1%) deaths. Drop-out from pre-ART care did not
vary significantly by gender or pregnancy (data not shown). Of the
55 participants retained in pre-ART care, 28 (50.9%) had
collected co-trimoxazole within the last 3-months.
Mortality during Cohort Follow-up
By 6-months, 15/280 (5.4%) participants had died (mortality
rate 14.8 per 100 person-years, 95% CI: 8.9–24.6 per 100 person-
years). Eleven of fifteen deaths (73.3%) occurred following ART
initiation. The median time from HIV diagnosis to death in
participants who initiated ART was 40 days (IQR: 39–48) and
from ART initiation to death was 38 days (IQR: 24–103 days).
Figure 2. Completion of pre-ART care stages if received same-day WHO clinical staging.
doi:10.1371/journal.pone.0044794.g002
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Discussion
The main finding from this study, which is the first prospective
cohort from primary care level, and the first prospective study
outside of South Africa, was that linkage to ART was high among
individuals who were promptly assessed for ART eligibility and
found to be ART eligible, but that outcomes were substantially
worse for individuals who did not complete same-day ART
eligibility assessments, with extremely low uptake of ART and
poor retention in pre-ART care. Although completion of ART
eligibility assessment was suboptimal for all groups, pregnant
women fared particularly badly. This emphasises the need to
simplify and streamline ART eligibility assessments with an urgent
need to prioritise same-day assessment in National programme
policies.
The high reported risk of failure of linkage from HIV diagnosis
to initiation of ART following a positive HIV test in sub-Saharan
Africa is based on a small number of mostly retrospective studies
[10,11,18,19,20,21,22,23,24,25,26,27,28] with a systematic review
Figure 3. Kaplan-Meier plots of initiation of ART by (a) sex and pregnancy; and (b) self-rated general health.
doi:10.1371/journal.pone.0044794.g003
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estimating that only one-third to one-sixth of patients will
complete all steps in the HIV care pathway and initiate ART
[5]. The authors concluded by calling for more prospective data
from high HIV prevalence countries in order to inform policy [5].
The lack of capacity for same-day ART eligibility assessments
appears to be the key barrier in this setting: only half of
participants were WHO clinically staged by 6-months and
successful completion of CD4 count measurement was extremely
low. Clinical staging was originally intended to be used as
a diagnostic tool for HIV in low resource settings prior to the
widespread availability of rapid test kits [29], and was then
adopted for defining endpoints in clinical trials. The WHO clinical
staging system is known to have a relatively low sensitivity for
identifying the currently recommended CD4 cut-off for ART
initiation [30] and includes a number of conditions that cannot be
diagnosed in most resource poor settings. It is therefore un-
necessarily time-consuming and overly complex for use as an ART
eligibility assessment tool and as our data suggests, this results in
frequent failure to stage immediately after testing HIV-positive.
Only one-third of participants referred for CD4 count
measurement returned to the clinic with a result. This was worse
than reported in a hospital-based HIV cohort in South Africa,
where about one-half returned with a result [11]. We attribute the
low completion of CD4 measurement reported here to the greater
resource limitations in Malawi requiring participants to travel to
the city’s central hospital for venepuncture (with the lab machine
often out of action) and a further return trip required to collect
results. Other studies on HIV/TB integration in Malawi have
Table 2. Univariate and multivariate associations with ART initiation over 6-months (n = 280).
Univariate
hazard ratio 95% CI P-value
Multivariate
hazard ratio 95% CI P-value
Sex and pregnancy
Female non-pregnant 1
Male 1.29 0.81–2.04 1.29 0.78–2.14
Female pregnant 0.20 0.11–0.40 ,0.001 0.58 0.28–1.21 0.316
BMI (kg/m2) – continuous 0.83 0.77–0.89 ,0.001 0.96 0.89–1.04 0.312
Age (years) - continuous 1.05 1.04–1.07 ,0.001 1.01 0.99–1.04 0.341
Employment status
Not in formal employment 1
In formal employment 1.25 0.81–1.90 0.306
Literacy
Able to read a newspaper 1
Illiterate 0.81 0.46–1.43 0.459
Wealth quartile*
Poorest quartile 1
Next poorest quartile 1.01 0.55–1.83
Next wealthiest quartile 0.75 0.39–1.43
Wealthiest quartile 0.61 0.31–1.20 0.372
Self-reported general health
Excellent 1 1
Good 2.21 0.86–5.64 1.70 0.65–4.49
Fair 8.48 3.62–19.88 2.87 1.11–7.40
Poor 13.70 5.44–34.51 ,0.001 3.16 1.11–8.93 0.104
Study assessed WHO clinical stage
Stage 1 or 2 1 1
Stage 3 or 4 3.25 1.89–5.60 ,0.001 1.00 0.54–1.85 0.992
Health facility
Chilomoni Health Centre 1 1
Ndirande Health Centre 0.66 0.42–1.02 0.056 0.94 0.46–1.95 0.876
Received same-day WHO staging 1.66 1.08–2.55 0.019 0.72 0.36–1.43 0.349
Eligibility assessment at 6 months
ART eligible 1 1
Not ART eligible 0.16 0.07–0.36 0.19 0.08–0.44
Not fully assessed 0.07 0.04–0.12 ,0.001 0.11 0.06–0.21 ,0.001
*Proxy means test for household wealth: variable constructed from asset ownership (fridge, car or motorbike, bed), mean household size, squared mean household size,
mean age of household head, education level of household head, mean number of salaried household members, household lighting source is electricity or gas.
Constructed as a continuous measure with higher values representative of wealthier household.
doi:10.1371/journal.pone.0044794.t002
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shown a pronounced effect on retention in care when travel
between clinics is required, a process that is known to be expensive
and time-consuming [20].
Ideally, all patients should be guaranteed same-day ART
eligibility assessment following HIV diagnosis, without the need to
visit multiple clinics. Using a ‘‘test and treat’’ approach is one
option [31]. Alternatively, we suggest development and validation
of clinical algorithms expressly designed for ascertaining ART
eligibility status and with sufficient simplicity to be carried out by
front-line health workers, including community health workers. If
CD4 counts are required, they should be point-of-care [32,33].
Pre-ART care registers directly completed once HIV infection has
been confirmed would allow appropriate monitoring and report-
ing of linkage and retention, and tracing of patients lost to care
[34].
Also notable is our finding that pregnant women were at
particularly at risk of failure to complete ART eligibility
assessments and were less likely to initiate ART. Health systems
factors (especially crowded antenatal clinics, staff shortages and
inaccessibility of CD4 count measurements) were reported as
being the major barriers to pregnant women’s completion of ART
eligibility assessments in a linked qualitative study [17]. Pregnant
women underwent HTC at an earlier stage of HIV infection as
shown by WHO stage, CD4 count (where completed) and self-
rated general health and this may explain why they were less likely
to initiate ART than men and non-pregnant women. Longer-term
follow-up of pregnant women’s uptake of ART will be required to
confirm this. Nevertheless, These findings have major implications
for efforts to reduce maternal mortality and eliminate mother-to-
child transmission, although in Malawi, following the completion
of this study, universal life-long triple therapy for HIV-positive
pregnant women (‘‘Option B+’’) has been introduced, hopefully
bypassing the problems of suboptimal ART eligibility assessments
and delayed ART initiation [35].
All of our participants were extremely poor, but greater poverty
was not a significant risk factor for failure to initiate ART. There
was a trend towards failure to be retained in pre-ART care among
our poorest participants. Other studies in Malawi show that TB
suspects spend a large proportion of their annual household
income simply to complete the investigations required to access
TB treatment [36]. Although we did not investigate expenditure
here, it is likely that the cost of making repeat clinic visits required
for ART eligibility assessment are similarly financially draining
and so likely to contribute to drop-out from HIV care-seeking.
Mortality in our cohort was 5%, with most deaths occurring
after initiation of ART. There are few other data on mortality
during pre-ART care-seeking [26]. The immediate post-ART
initiation period is known to be high risk for mortality [8],
especially for patients with advanced immunosuppression. Di-
agnosing HIV early in the course of infection and reducing delays
to treatment initiation reduces mortality in observational studies
[37].
There were a number of limitations to this study. Only patients
attending at two primary health care centres were studied,
although these clinics are the two largest primary care providers
of ART in Blantyre. Our results may not be generalizable to HIV
programmes in other settings that are structured differently. We
did not measure CD4 counts in this study, as this would have
constituted an intervention in the care-seeking process. As such,
we cannot ascertain the true proportion of individuals who were
eligible for ART. We were able to recruit a maximum of six
participants per clinic per day due to time and space constraints.
This may have resulted in some selection bias in participant
recruited. However, as previously reported [17], characteristics of
HIV participants recruited and not recruited to the study were
similar. Reasons for undergoing HTC may have influenced
linkage to ART, but sufficient data on testing behaviour was not
captured in this study to allow this to be explored. With telephone
and home tracing, our loss to follow-up was 11%, which is lower
than the majority of other studies investigating pre-ART patients,
but may conceal missed events such as initiation of ART or death.
Mortality may be an important cause of pre-ART attrition and
larger studies are required to give further insights into the extent of
and factors associated with death.
In summary, this prospective cohort study recruiting newly
diagnosed HIV-positive patients from primary care has identified
the critical need for same-day ART eligibility assessments, with
need for point of care CD4 counts if these are to be used as part of
staging. Failure to provide same-day staging resulted in poor
completion of ART assessments and high rates of drop-out from
care. HIV care programmes in this region should revaluate the
way that testing is linked to care, with concerted effort clearly
needed to improve rates of linkage to ART. This should include
guarantee of a same-day, simplified ART eligibility assessment
(potentially incorporating point of care CD4 measurement) and
patient registers that cover the whole HIV care pathway.
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